| Bioactivity | Clezutoclax is a potent payload and also a Bcl-XL inhibitor. Clezutoclax can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
| Target | Bcl-XL |
| Name | Clezutoclax |
| CAS | 1949843-71-3 |
| Formula | C83H102N12O24S2 |
| Molar Mass | 1715.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Boni V, et al. The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-17. |
Clezutoclax
CAS: 1949843-71-3 F: C83H102N12O24S2 W: 1715.89
Clezutoclax is a potent payload and also a Bcl-XL inhibitor. Clezutoclax can be used in the synthesis of antibody-drug c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.